These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36639062)

  • 61. Free water in gray matter linked to gut microbiota changes with decreased butyrate producers in Alzheimer's disease and mild cognitive impairment.
    Yamashiro K; Takabayashi K; Kamagata K; Nishimoto Y; Togashi Y; Yamauchi Y; Ogaki K; Li Y; Hatano T; Motoi Y; Suzuki M; Miyakawa K; Ishikawa D; Aoki S; Urabe T; Hattori N
    Neurobiol Dis; 2024 Apr; 193():106464. PubMed ID: 38452948
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
    Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK
    J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Regional Disconnection in Alzheimer Dementia and Amyloid-Positive Mild Cognitive Impairment: Association Between EEG Functional Connectivity and Brain Glucose Metabolism.
    Smailovic U; Koenig T; Savitcheva I; Chiotis K; Nordberg A; Blennow K; Winblad B; Jelic V
    Brain Connect; 2020 Dec; 10(10):555-565. PubMed ID: 33073602
    [No Abstract]   [Full Text] [Related]  

  • 64. Neural Correlates of Cognitive Performance in Alzheimer's Disease- and Lewy Bodies-Related Cognitive Impairment.
    Chung SJ; Jeon S; Yoo HS; Lee YH; Yun M; Lee SK; Lee PH; Sohn YH; Evans AC; Ye BS
    J Alzheimers Dis; 2020; 73(3):873-885. PubMed ID: 31868668
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Molecular imaging of serotonin degeneration in mild cognitive impairment.
    Smith GS; Barrett FS; Joo JH; Nassery N; Savonenko A; Sodums DJ; Marano CM; Munro CA; Brandt J; Kraut MA; Zhou Y; Wong DF; Workman CI
    Neurobiol Dis; 2017 Sep; 105():33-41. PubMed ID: 28511918
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Proper names from story recall are associated with beta-amyloid in cognitively unimpaired adults at risk for Alzheimer's disease.
    Mueller KD; Koscik RL; Du L; Bruno D; Jonaitis EM; Koscik AZ; Christian BT; Betthauser TJ; Chin NA; Hermann BP; Johnson SC
    Cortex; 2020 Oct; 131():137-150. PubMed ID: 32861209
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Does resting state functional connectivity differ between mild cognitive impairment and early Alzheimer's dementia?
    Soman SM; Raghavan S; Rajesh PG; Mohanan N; Thomas B; Kesavadas C; Menon RN
    J Neurol Sci; 2020 Nov; 418():117093. PubMed ID: 32827882
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.
    Espinosa A; Alegret M; Pesini P; Valero S; Lafuente A; Buendía M; San José I; Ibarria M; Tejero MA; Giménez J; Ruiz S; Hernández I; Pujadas F; Martínez-Lage P; Munuera J; Arbizu J; Tárraga L; Hendrix SB; Ruiz A; Becker JT; Landau SM; Sotolongo-Grau O; Sarasa M; Boada M; ;
    J Alzheimers Dis; 2017; 57(2):447-459. PubMed ID: 28269787
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tau-related grey matter network breakdown across the Alzheimer's disease continuum.
    Pelkmans W; Ossenkoppele R; Dicks E; Strandberg O; Barkhof F; Tijms BM; Pereira JB; Hansson O
    Alzheimers Res Ther; 2021 Aug; 13(1):138. PubMed ID: 34389066
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Planning in amnestic mild cognitive impairment: an fMRI study.
    Lejko N; Tumati S; Opmeer EM; Marsman JC; Reesink FE; De Deyn PP; Aleman A; Ćurčić-Blake B
    Exp Gerontol; 2022 Mar; 159():111673. PubMed ID: 34958871
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Preliminary investigation of cognitive function in aged multiple sclerosis patients: Challenges in detecting comorbid Alzheimer's disease.
    Roy S; Drake A; Snyder S; Cline B; Khan A; Fuchs T; Zivadinov R; Weinstock-Guttman B; Szigeti K; Benedict RHB
    Mult Scler Relat Disord; 2018 May; 22():52-56. PubMed ID: 29574353
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cortical thickness is associated with altered autonomic function in cognitively impaired and non-impaired older adults.
    Lin F; Ren P; Wang X; Anthony M; Tadin D; Heffner KL
    J Physiol; 2017 Nov; 595(22):6969-6978. PubMed ID: 28952161
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prediction of Incipient Alzheimer's Disease Dementia in Patients with Mild Cognitive Impairment.
    Ardekani BA; Bermudez E; Mubeen AM; Bachman AH;
    J Alzheimers Dis; 2017; 55(1):269-281. PubMed ID: 27662309
    [TBL] [Abstract][Full Text] [Related]  

  • 75. MRI-based Alzheimer's disease-resemblance atrophy index in the detection of preclinical and prodromal Alzheimer's disease.
    Liu W; Au LWC; Abrigo J; Luo Y; Wong A; Lam BYK; Fan X; Kwan PWL; Ma HW; Ng AYT; Chen S; Leung EYL; Ho CL; Wong SHM; Chu WC; Ko H; Lau AYL; Shi L; Mok VCT;
    Aging (Albany NY); 2021 May; 13(10):13496-13514. PubMed ID: 34091443
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Predicting Conversion from Subjective Cognitive Decline to Mild Cognitive Impairment and Alzheimer's Disease Dementia Using Ensemble Machine Learning.
    Dolcet-Negre MM; Imaz Aguayo L; García-de-Eulate R; Martí-Andrés G; Fernández-Matarrubia M; Domínguez P; Fernández-Seara MA; Riverol M
    J Alzheimers Dis; 2023; 93(1):125-140. PubMed ID: 36938735
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Brain microstructure reveals early abnormalities more than two years prior to clinical progression from mild cognitive impairment to Alzheimer's disease.
    Douaud G; Menke RA; Gass A; Monsch AU; Rao A; Whitcher B; Zamboni G; Matthews PM; Sollberger M; Smith S
    J Neurosci; 2013 Jan; 33(5):2147-55. PubMed ID: 23365250
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Olfactory Phenotypes Differentiate Cognitively Unimpaired Seniors from Alzheimer's Disease and Mild Cognitive Impairment: A Combined Machine Learning and Traditional Statistical Approach.
    Li J; Bur AM; Villwock MR; Shankar S; Palmer G; Sykes KJ; Villwock JA
    J Alzheimers Dis; 2021; 81(2):641-650. PubMed ID: 33843686
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mild behavioral impairment in early Alzheimer's disease and its association with APOE and BDNF risk genetic polymorphisms.
    Matuskova V; Veverova K; Jester DJ; Matoska V; Ismail Z; Sheardova K; Horakova H; Cerman J; Laczó J; Andel R; Hort J; Vyhnalek M
    Alzheimers Res Ther; 2024 Jan; 16(1):21. PubMed ID: 38279143
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A comparative study: visual rating scores and the voxel-based specific regional analysis system for Alzheimer's disease on magnetic resonance imaging among subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.
    Li F; Takechi H; Saito R; Ayaki T; Kokuryu A; Kuzuya A; Takahashi R
    Psychogeriatrics; 2019 Mar; 19(2):95-104. PubMed ID: 30276926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.